NeuroSigma’s leadership is made up of experts in business management and the healthcare industry. Together they provide extensive experience gained through years of creating and guiding successful companies and by conducting years of medical research.

Colin Kealey, M.D.


Colin previously served as a researcher at UCLA's Center for Advanced Surgical and Interventional Technology (CASIT). His work at CASIT focused on the development of next-generation medical devices based on Thin-Film Nitinol (TFN) technology, as well as novel Terahertz (THz) imaging systems. Over the past three years his work has helped advance TFN covered stents towards commercialization. He also assisted in the formation of NSVascular, a wholly-owned subsidiary of NeuroSigma.

Colin received a BS in Biochemistry and Molecular Biology from the University of Wisconsin - Madison, and an MD from the University of Iowa Carver College of Medicine.